References
- Umland EM. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J Manag Care Pharm 2008;14:14–19
- Anderson D, Yoshizawa T, Gollschewski S, Atogami F, Courtney M. Relationship between menopausal symptoms and menopausal status in Australian and Japanese women: preliminary analysis. Nurs Health Sci 2004;6:173–180
- Lee S-S, Shin D-I. Digital acroparesthesia caused by pontine infarction. Clin Neurol Neurosurg 2008;110:641–643
- Zakrzewska-Pniewska B, Jedras M. Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR). Neurophysiol Clin 2001; 31:181–193
- Poza JJ, Cobo AM, Martí-Massó JF. Peripheral neuropathy associated with polycythemia vera. Neurologia 1996;11:276–279
- Hillard TC, Bourne TH, Whitehead MI, Crayford TB, Collins WP, Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992;58:959–964
- Genazzani AR, Mannella P, Simoncini T. Drospirenone and its antialdosterone properties. Climacteric 2007;10(Suppl 1):11–18
- Mallareddy M, Hanes V, White WB. Drospirenone, a new progestogen, for postmenopausal women with hypertension. Drugs Aging 2007;24:453–466
- Battaglia C, Salvatori M, Gallinelli A, Artini PG, Genazzani AR, Volpe A. Color Doppler and hormone replacement therapy: the role of thromboxane and plasma viscosity. Gynecol Endocrinol 1999;13:183–188
- Sanada M, Higashi Y, Nakagawa K, et al Oral estrogen replacement therapy increases forearm reactive hyperemia accompanied by increases in serum levels of nitric oxide in postmenopausal women. Gynecol Endocrinol 2001;15:150–157